Search results
Keeping an Eye on Abbvie Inc
Knox Daily· 16 hours agoAbbvie Inc’s recently made public that its EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas unloaded Company’s shares for reported $3.72 ...
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoOngoing legal proceedings, such as those mentioned in the 10-Q filing, highlight the potential for costly and time-consuming disputes that could impact...
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks via Yahoo Finance· 6 days agoPharmaceuticals industry, to which AbbVie belongs, has lost 1.9% over this period. Now the key...
10 Best May Dividend Stocks To Buy
Insider Monkey via Yahoo Finance· 1 day agoIn this article, we discuss 10 best May dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their past performance, and go...
Michael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks By Investing.com
Investing.com· 4 days agoMichael Burgess trades in AbbVie, IBM, iShares ETF, and Merck stocks
AbbVie (NYSE:ABBV) Shares Down 0.5% After Analyst Downgrade
ETF DAILY NEWS· 7 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares fell 0.5% on Monday after Barclays lowered their price target on the stock from $195.00 to $187.00. AbbVie ...
Healthcare and drugmaker groups seek to revive challenge to US drug-pricing law
Reuters· 6 days agoHealthcare and drug industry groups on Wednesday urged a U.S. appeals court to revive their...
Top 25 Stocks in the S&P 500 by Index Weight Right Now
Insider Monkey via Yahoo Finance· 5 days agoIn this piece, we will take a look at the top 25 stocks in the S&P 500 by index weight right now. If...
Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar?
Zacks via Yahoo Finance· 1 day agoLooking at individual holdings, Chevron Corporation (CVX) accounts for about 9.68% of total assets,...
Cencora beats profit estimates on strong demand for costly specialty drugs
Reuters· 6 days ago, opens new tab beat Wall Street estimates for second-quarter profit on Wednesday, driven by robust demand for costly specialty medicines that treat complex diseases such as cancer and rheumatoid ...